Levonorgestrel + ethinylestradiol
Stediril 30 is available in the form of a combined oral contraceptive tablet ("Tablet") for use in order to prevent pregnancy.
The medicine contains two types of female sex hormones: estrogen and progestogen. These hormones prevent pregnancy by acting in three ways: they prevent the release of the egg from the ovaries; they thicken the mucus in the cervix, making it difficult for sperm to penetrate the uterus; they prevent the thickening of the uterine lining so that a fertilized egg cannot develop in it.
Stediril 30 should be taken daily for 21 days (1 tablet), after which there is a 7-day break from taking the tablet.
Stediril 30 does not protect against sexually transmitted infections, such as chlamydia or HIV. Only condoms protect against these infections.
It is essential to understand the benefits and risks associated with taking the Tablet before starting to take it or deciding to continue it. Although the Tablet is suitable for most healthy women, it is not suitable for all of them.
You should inform your doctor if you have any diseases or risk factors mentioned in this leaflet.
The doctor will ask a few questions about your health and the health of your close relatives and measure your blood pressure.
The doctor should also perform other tests, such as a breast examination.
Taking Stediril 30 will pose a risk to your health:
If you have any of the above conditions or if they occur for the first time while taking Stediril 30, you should contact your doctor as soon as possible. Do not take Stediril 30.
If these symptoms occur or worsen while taking Stediril 30, you should also tell your doctor.
A serious risk factor or multiple risk factors for venous or arterial thrombosis may also be a contraindication (see "Warnings and precautions, Tablet and thrombosis").
Women taking the Tablet are strongly advised to quit smoking.
Smoking increases the risk of serious side effects from the heart and circulatory system. This risk increases with age and the number of cigarettes smoked and is significant in women over 35 years old.
The Tablet may slightly increase the risk of blood clots (called thrombosis), especially in the first year of use.
A blood clot in a leg vein - deep vein thrombosis - is not always serious. However, if it moves from the veins to the lungs, it can cause chest pain, shortness of breath, collapse or even death. This condition is called pulmonary embolism and is very rare.
The risk of blood clots is only slightly increased by taking the Tablet.
The risk of blood clots in the veins increases further:
Symptoms of a blood clot include:
Blood clots can also form in the blood vessels of the heart (causing a heart attack) or brain (causing a stroke) in rare cases. In young, healthy women, the risk of a heart attack or stroke is extremely low.
The risk of a heart attack or stroke increases further:
Symptoms of a heart attack or stroke include:
Surgery and immobilization
You should stop taking the Tablet 4 weeks before planned surgery and 2 weeks after surgery that increases the risk of thrombosis, or during prolonged immobilization. You should discuss taking the Tablet with your doctor in such situations.
Childbirth, abortion or miscarriage
After childbirth, there is an increased risk of blood clots. You should not start taking the Tablet earlier than 28 days after childbirth if you are breastfeeding.
The same applies to abortion or miscarriage after the first three months of pregnancy.
Taking the Tablet for a long time reduces the risk of ovarian and endometrial cancer. However, it appears to slightly increase the risk of cervical cancer- although this may be due to sexual behavior rather than taking the tablet. The most important risk factor for cervical cancer is persistent human papillomavirus infection.
All women should have regular cervical smears.
If you have or have had breast cancerin the past, you should not take the Tablet.
The Tablet slightly increases the risk of breast cancer. This risk increases with the duration of taking the Tablet, but decreases within 10 years of stopping it.
Breast cancer rarely occurs in women under 40, so the risk of additional breast cancer cases in women currently or recently taking the Tablet is small.
The risk of breast cancer is higher:
Very rarely, taking the Tablet has also been associated with certain types of liver cancerin women taking the medicine for a long time.
Taking the Tablet has also been rarely associated with liver disease, such as jaundice and non-cancerous liver tumors.
Early diagnosis of liver cell damage allows for prompt withdrawal of the medicine, which reduces the harmful effect of the medicine on the liver. If liver cell damage is diagnosed, you should stop taking the Tablet, use other methods of contraception and consult your doctor.
It may be that the Tablet cannot be used until liver function disorders have subsided.
If you experience severe abdominal pain or yellowing of the skin or eyes (jaundice), you should contact your doctor as soon as possible. It may be necessary to stop taking Stediril 30.
When wearing contact lenses, discomfort or even intolerance may occur while taking the Tablet. If more serious eye problems occur, you should stop taking the Tablet and consult your doctor immediately.
While taking the tablet, high blood pressure may occur. If you have ever had high blood pressure problems, you may need to use another method of contraception. If your doctor prescribes the Tablet, you should have your blood pressure checked regularly and stop taking the Tablet and use another method of contraception if it increases significantly (see also "Do not take Stediril 30 if you have any of the following conditions").
If you experience migraines or headaches, in a form that has not occurred before, the Tablet may not be suitable. In this case, you should stop taking the Tablet and consult your doctor.
The Tablet may cause or worsen symptoms of angioedema (sudden swelling of tissues in some cases causing difficulty breathing, swallowing and hives).
The increased risk occurs if you or your relatives have ever had angioedema. You should consult your doctor.
If you have ever had problems with glucose tolerance or diabetes, you should tell your doctor, as close monitoring of you may be required (see also "Do not take Stediril 30 if you have any of the following conditions").
In a small number of women, changes in blood lipid levels may occur while taking the Tablet. You should inform your doctor, who may consider using non-hormonal contraception.
If you are being treated for high lipid levels, regular check-ups will be required while taking the Tablet.
Irregular vaginal bleeding may occur (unexpected bleeding outside the weekly break, when you are not taking the medicine) or spotting, especially during the first three months of taking the Tablet. A reliable assessment of irregular bleeding is possible only after an adaptation period of about three cycles. If these forms of bleeding persist or recur, you should consult your doctor to rule out non-hormonal causes, such as pregnancy or certain diseases. If necessary, your doctor may prescribe another Tablet (see also "Vaginal bleeding should not last long").
If you have previously had amenorrhea or irregular periods, these conditions may recur while taking the Tablet.
In the case of amenorrhea during taking the Tablet, see also "Missing a dose of Stediril 30".
Some women taking hormonal contraceptives, including Stediril 30, have reported depression or low mood. Depression can be severe and sometimes lead to suicidal thoughts. If mood changes or symptoms of depression occur, you should contact your doctor as soon as possible for further medical advice.
Women with a history of depression should be closely monitored and if severe symptoms of recurring depression occur, you should stop taking the product. It may turn out that the tablet is not suitable and another type of contraception will be needed.
Before prescribing the Tablet for the first time, your doctor will take a complete medical history, including family history, and perform a physical examination. You should regularly visit your doctor for a cervical smear test.
The next visit should take place after three months from the start of taking the Tablet. Once a year, you should visit your doctor for a check-up, which will be the same as the first one.
While taking the Tablet, in patients who have had chloasma in the past, brown spots on the face (chloasma) may occur. Patients prone to chloasma should avoid sun exposure and ultraviolet radiation.
Stediril 30 is intended for use only in women of reproductive age. It should not be used by children or postmenopausal women.
You should tell your doctor or pharmacist about all medicines you are currently taking or have recently taken, as well as any medicines you plan to take. You should also check the leaflets of all medicines you are taking to see if they can be used with hormonal contraception.
Some medicines may make Stediril 30 less effective in preventing pregnancy, for example:
If it is necessary to take one of these medicines, it may turn out that Stediril 30 is not suitable and there is a need to use additional contraception for a certain period. Your doctor or pharmacist will inform you if this is necessary and for how long.
Stediril 30 may also affect the action of other medicines. Therefore, it is very important to tell your doctor if you are taking the Tablet with other medicines.
Taking a medicine called troleandomycin while taking the Tablet increases the risk of liver function disorders (reduced bile secretion by the liver).
Taking a medicine called flunaryzine while taking the Tablet may sometimes cause milk production in the breasts of women who have not recently given birth.
You should not take Stediril 30 if you have hepatitis C and are taking antiviral medicines containing ombitasvir with paritaprevir and ritonavir, dasabuvir, glecaprevir with pibrentasvir or sofosbuvir with velpatasvir and voxilaprevir, as these medicines may cause elevated liver function test results (increased activity of the liver enzyme ALT).
Your doctor will suggest another type of contraception before starting these medicines.
You can resume taking Stediril 30 about 2 weeks after finishing the treatment. See "When not to take Stediril 30".
There are no special recommendations for taking Stediril 30 with food and drink.
In pregnancy and during breastfeeding or if you suspect you are pregnant, or if you plan to become pregnant, you should consult your doctor before taking this medicine.
You should not take Stediril 30 during pregnancy. If you suspect you are pregnant, you should have a pregnancy test done before stopping Stediril 30.
There is no evidence that Stediril 30 causes harm to the fetus if it is taken inadvertently during use, but if pregnancy is confirmed, you should stop taking Stediril 30.
Stediril 30 is not recommended during breastfeeding. You should discuss another method of contraception with your doctor. Breastfeeding does not protect against pregnancy.
Stediril 30 contains lactose and sucrose. You should inform your doctor before starting to take the medicine if you have an intolerance to some sugars.
This medicine should always be taken according to the doctor's instructions. If you have any doubts, you should consult your doctor.
Stediril 30 should be taken daily for 21 days.
Stediril 30 is available in blisters containing 21 tablets. Each tablet is marked with the day of the week.
Then there is a 7-day break from taking the tablets
After taking all 21 tablets from the blister, there is a 7-day break from taking the tablets. If the last tablet from the first pack was taken on a Friday, the first tablet from the next pack should be taken on the following Saturday.
Within a few days of taking the last tablet from the blister, withdrawal bleeding will occur, similar to a menstrual period. This bleeding may not have stopped before starting the next pack of tablets.
There is no need to use additional contraception during these 7 tablet-free days, as long as the tablets are taken correctly and the next pack is started on time.
Then you should start the next pack
After the 7 tablet-free days, you should start the next blister of Stediril 30 - even if the bleeding has not stopped. You should always start a new blister on time.
As long as the tablets are taken correctly, each subsequent pack will always start on the same day of the week.
First use or starting the Tablet after a break
You should start taking Stediril 30 on the first day of your next menstrual period. Starting in this way provides immediate contraceptive protection.
It is acceptable to start taking Stediril 30 between the 2nd and 7th day of your menstrual period (e.g. starting on a Sunday). You should use additional methods of contraception, such as condoms, until you have taken the first seven tablets correctly.
Switching from another contraceptive to Stediril 30
Starting Stediril 30 after a miscarriage or abortion
If the miscarriage or abortion occurred within the first three monthsof pregnancy, your doctor may inform you that you can start taking Stediril 30 immediately. This means that you will have immediate contraceptive protection.
If the miscarriage or abortion occurred after the third monthof pregnancy, you can start taking Stediril 30 after 28 days. It is recommended to use additional methods of contraception, such as condoms, during the first 7 days of taking the medicine. If you have had sexual intercourse, you should rule out pregnancy or wait for your next menstrual period to occur.
Contraception after childbirth
You can start taking Stediril 30 after 28 days from a normal, uncomplicated childbirth, if you are not breastfeeding and are fully recovered. It is recommended to use additional methods of contraception during the first 7 days of taking Stediril 30.
If you have had sexual intercourse, you should rule out pregnancy or wait for your first menstrual period after childbirth or abortion to occur.
Your doctor will provide further information on contraception.
It is unlikely that taking more than one tablet will cause side effects, but you should talk to your doctor as soon as possible.
If you miss a tablet, you should follow the instructions below.
If it has been less than 12 hourssince you missed the tablet, you should take the missed tablet as soon as possible. You should take the next tablets at the usual time. Contraceptive protection has not been reduced.
If it has been more than 12 hourssince you missed the tablet or if you have missed two or more active tablets, contraceptive protection may be reduced. Therefore, you should take only the last missed tablet as soon as possible, which may mean taking two tablets on the same day. Previously missed tablets should be left in the blister and you should continue taking the tablets as usual. You should also use additional methods of contraception, such as condoms, for the next seven days.
You should follow the rules below:
If you forgot to take any of the tablets from the blister and did not have withdrawal bleeding during the tablet-free period, it may mean that you are pregnant. Before starting the tablets from the next blister, you should contact your doctor or pharmacist or have a pregnancy test.
If you started a new blister late, you may not be protected against pregnancy. If you have had sexual intercourse, you should consult your doctor or pharmacist. You should also use additional methods of contraception, such as condoms, for seven days.
If you vomit or have severe diarrhea, the hormones from the tablet may not have been fully absorbed. You should continue taking the tablets at the usual time. You should use additional contraception, such as condoms, during the illness and for the next seven days after recovery. If it has been more than 12 hours, you should follow the instructions from the "Missing a dose of Stediril 30" section.
You should contact your doctor if gastrointestinal disturbances do not subside or worsen. Your doctor may recommend another method of contraception.
Occasionally, withdrawal bleeding may not occur. This may mean that you are pregnant, but it is unlikely if the tablets have been taken correctly. If there is a risk of pregnancy (e.g. due to missing a tablet or taking other medicines) before starting the next pack, you should have a pregnancy test. If it turns out that you are pregnant, you should stop taking Stediril 30 and consult your doctor.
If you want to delay the time of withdrawal bleeding, you should skip the 7-day break and immediately start taking tablets from a new pack of Stediril 30. You can delay withdrawal bleeding for any length of time, up to the time you take all the tablets from the new pack. During this time, you may experience irregular bleeding or spotting.
You should resume regular taking of Stediril 30 after the usual 7-day break.
If you have any further questions about taking this medicine, you should talk to your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
You should contact your doctor immediately if you experience any of the following symptoms of angioedema: swelling of the face, tongue and (or) throat, and (or) difficulty swallowing or hives, which can cause difficulty breathing (see also "Warnings and precautions").
Like all medicines, Stediril 30 may cause allergic reactions (hypersensitivity). These reactions may include, in very rare cases, hives, sudden swelling of tissues and severe reactions from the respiratory and circulatory systems, such as: decreased blood pressure, dizziness, nausea and difficulty breathing. If you notice any symptoms of an allergic reaction, you should stop taking Stediril 30 immediately and consult your doctor or go to the nearest hospital.
Severe side effects related to taking the contraceptive tablet have been described in section 2, "Tablet and thrombosis" and "Tablet and cancer". If you need further information, you should read these sections.
Very common (occurring in more than 1 in 10 women):
Common (occurring in 1 to 10 in 100 women):
Uncommon (occurring in 1 to 10 in 1,000 women):
Rare (occurring in 1 to 10 in 10,000 women):
Very rare (occurring in less than 1 in 10,000 women):
Stediril 30 may also cause inflammatory bowel disease (e.g. Crohn's disease, ulcerative colitis) and liver cell damage with an unknown frequency, which cannot be determined from the available data.
You should inform your doctor or pharmacist if you suspect that any side effect may be caused by Stediril 30. If any of your existing disorders worsen while taking Stediril 30, you should also inform your doctor or pharmacist.
In some women, unexpected vaginal bleeding may occur while taking Stediril 30, especially during the first few months. Usually, this bleeding is not a cause for concern and will subside after a day or two. You should take Stediril 30 as usual. The problem should subside after taking a few initial blisters of the medicine.
Unexpected bleeding may also occur if the tablets are not taken regularly, so you should try to take the tablets daily at the same time. Unexpected bleeding may also be caused by taking other medicines.
You should consult your doctor if bleeding or spotting:
The medicinal product should be stored out of sight and reach of children. Do not use this medicinal product after the expiry date stated on the blister or carton after (EXP). The expiry date refers to the last day of the given month. Do not store above 25°C. Store in the original package. Medicines should not be disposed of via wastewater or household waste containers. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Coated tablets
The tablets are white, shiny, coated with a smooth surface.
Each blister of Stediril 30 contains 21 white tablets.
PVC/Aluminium foil blister in an aluminium sachet with silica gel as a desiccant, in a cardboard box.
PVC/Aluminium foil blister in a cardboard box.
Each pack of Stediril 30 contains 1x21 or 3x21 tablets.
Not all pack sizes may be marketed.
Pfizer Europe MA EEIG
Boulevard de la Plaine 17
1050 Brussels
Belgium
Haupt Pharma Muenster GmbH
Schleebrueggenkamp 15
48159 Muenster
Germany
Pfizer Ireland Pharmaceuticals Unlimited Company
Little Connell, Newbridge
Co. Kildare
W12 HX57
Ireland
tel. 22 335 61 00
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.